论文信息 - Real-world dosing of regorafenib in metastatic colorectal cancer (mCRC): Interim analysis from the prospective, observational CORRELATE study. - 字舞流文

Real-world dosing of regorafenib in metastatic colorectal cancer (mCRC): Interim analysis from the prospective, observational CORRELATE study.

W. Scheithauer | C. Punt | M. Ducreux | K. Yeh | J. Metges | A. Falcone | Jen‐Kou Lin | A. Cervantes | J. Thaler | S. Fiala-Buskies | L. Öhler | L. Dourthe | L. Petersen | J. Kalinovský | Manuel O'Connor Juan | Willem de Groot Jan